Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

November 30, 2024

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

Pre-Exposure Prophylaxis (PrEP)

FDA-approved oral medication to reduce the risk of HIV infection

BEHAVIORAL

SPARK

SPARK is delivered in a clinic setting by a counselor using motivational interviewing techniques (e.g., open-ended questions, affirmations).

BEHAVIORAL

HealthMpowerment

PrEP adherence support app that utilizes engaging social networking and game-based elements, with an in-app portal for individualized live adherence counseling.

Trial Locations (3)

10032

Columbia University School of Nursing, New York

Unknown

Romanian Association Against AIDS, Bucharest

Romanian Association Against AIDS, Cluj-Napoca

All Listed Sponsors
collaborator

Yale University

OTHER

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

Columbia University

OTHER

NCT05323123 - Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries | Biotech Hunter | Biotech Hunter